AIG
ZNTL icon

American International Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History

American International Group’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,701
Closed -$452K – 2804
2024
Q1 		$452K Sell
28,701
-247
-0.9% -$3.4K ﹤0.01% 1710
2023
Q4 		$439K Sell
28,948
-117
-0.4% -$1.71K ﹤0.01% 1748
2023
Q3 		$583K Buy
29,065
+5,419
+23% +$138K ﹤0.01% 1516
2023
Q2 		$667K Buy
23,646
+987
+4% +$23.7K ﹤0.01% 1474
2023
Q1 		$390K Buy
22,659
+451
+2% +$9.13K ﹤0.01% 1741
2022
Q4 		$447K Sell
22,208
-81
-0.4% -$1.74K ﹤0.01% 1654
2022
Q3 		$483K Buy
22,289
+4,307
+24% +$118K ﹤0.01% 1597
2022
Q2 		$505K Sell
17,982
-121
-0.7% -$3.21K ﹤0.01% 1600
2022
Q1 		$835K Sell
18,103
-1,276
-7% -$68.8K ﹤0.01% 1437
2021
Q4 		$1.63M Sell
19,379
-270
-1% -$20.9K 0.01% 1165
2021
Q3 		$1.31M Buy
19,649
+1,019
+5% +$58.8K 0.01% 1281
2021
Q2 		$991 Buy
18,630
+1,875
+11% +$100K ﹤0.01% 1517
2021
Q1 		$727 Buy
16,755
+44
+0.3% +$1.89K ﹤0.01% 1631
2020
Q4 		$868 Buy
16,711
+9,819
+142% +$443K ﹤0.01% 1464
2020
Q3 		$225K Buy
6,892
+569
+9% +$19.9K ﹤0.01% 2078
2020
Q2 		$304K Buy
+6,323
New +$243K ﹤0.01% 1868

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

American International Group's ZNTL Position: Q2 2024 in Review

American International Group sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2024, closing a stake of 28,701 shares — an estimated $452K sold.

American International Group first reported a position in ZNTL in Q2 2020 and held it in 16 quarters. The position peaked at $1.63M in Q4 2021. 145 funds tracked by Wall St. Rank hold ZNTL as of Q2 2024.

  • American International Group reported no remaining Zentalis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 28,701 Zentalis Pharmaceuticals shares in Q2 2024, an estimated $452K.
  • American International Group first reported a position in Zentalis Pharmaceuticals in Q2 2020 and held it in 16 quarters.
  • American International Group's Zentalis Pharmaceuticals position peaked at $1.63M in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.